1988
DOI: 10.1016/s0021-9258(19)81587-9
|View full text |Cite
|
Sign up to set email alerts
|

Purification and characterization of a peptidoglycan-associated lipoprotein from Haemophilus influenzae.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1991
1991
2018
2018

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 31 publications
(4 citation statements)
references
References 28 publications
0
4
0
Order By: Relevance
“…However, indirect evidence indicates that it performs a A db c_ -738 bp structural function for the cell. P6 is a lipoprotein and is associated with peptidoglycan (47,48). Furthermore, P6 shares homology with the peptidoglycan-associated lipoprotein of Escherichia coli (48).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, indirect evidence indicates that it performs a A db c_ -738 bp structural function for the cell. P6 is a lipoprotein and is associated with peptidoglycan (47,48). Furthermore, P6 shares homology with the peptidoglycan-associated lipoprotein of Escherichia coli (48).…”
Section: Discussionmentioning
confidence: 99%
“…P6 is a lipoprotein and is associated with peptidoglycan (47,48). Furthermore, P6 shares homology with the peptidoglycan-associated lipoprotein of Escherichia coli (48). Therefore, it appears that P6 is the analog in H. influenzae of the peptidoglycan-associated lipoprotein in E. coli.…”
Section: Discussionmentioning
confidence: 99%
“…The mycoplasmal di-acylated lipopeptides lack the amide-bound lipid chain. Palmitoyl groups are the most common lipid chains in the bacterial lipoproteins but other lipid chains are also found (Belisle et al, 1994;Braun, 1975;Mizuno, 1979;Zlotnick et al, 1988). Synthetic lipopeptide analogs containing di-or tri-acylated cysteine groups mimic the proinflammatory properties of lipoproteins, thus confirming that the acylated N-terminal cysteine is the principal immune stimulatory motif (Berg et al, 1994;Bessler et al, 1985;Seifert et al, 1990;Wiesmu ¨ller et al, 1992).…”
Section: Introductionmentioning
confidence: 91%
“…A well-known protocol for the solubilization and purification of a bacterial wild-type PAL was first developed in 1988 (Zlotnick et al, 1988). However, although that protocol uses several ultracentrifugation steps, heat treatment, and detergents, it results in a low protein yield and is not appropriate for recombinant PAL-enriched inclusion bodies that are produced in E. coli.…”
Section: Commentary Background Informationmentioning
confidence: 99%